Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Opsens Inc. (T:OPS)

Business Focus: Advanced Medical Equipment & Technology

INK Edge Outlook

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for OPS within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Apr 21, 2021 07:00 ET
OpSens Integrates its OptoWire's dPR and FFR Algorithms Within Cathmedical Cardiovascular's Picasso System in Spain
AGREEMENT ALLOWS CARDIOLOGISTS TO PERFORM DPR AND FFR PROCEDURES USING OPSENS' OPTOWIRE AND CATHMEDICAL'S PICASSO SYSTEM IN AN INTEGRATED FASHION
Read full article
Apr 14, 2021 07:00 ET
OpSens Announces Second Quarter Fiscal 2021 Financial Results and Record FFR and dPR Revenues
QUEBEC CITY, April 14, 2021 /CNW Telbec/ - OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering diagnostic and treatment solutions based on its proprietary optical technology, today reported its financial results for the second quarter of fiscal 2021, ended February 28, 2021.
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
0.89
--
--
Price to Sales - TTM
7.51
25.97
14.55
Price to Book - most recent quarter
4.62
4.62
4.33
Price to Cash Flow per share - TTM
79.41
62.08
18.02
Price to Free Cash Flow per share - TTM
136.58
108.46
33.83
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Apr 30, 202143,80425,779
Apr 15, 202118,025-8,698
Mar 31, 202126,723-81
See Short Report

Business Summary

Sector:  Healthcare Industry:  Advanced Medical Equipment & Technology

Opsens Inc. provides fiber optic sensing technology. The Company operates through two segments: Medical and Industrial. In Medical segment, the Company focuses on the measure of Fractional Flow Reserve (FFR) in interventional cardiology. In Industrial segment, it develops, manufactures and installs fiber optic sensing solutions for critical applications, such as the monitoring of oil wells and other industrial applications. It is also involved in industrial activities. For the FFR market, it has developed the OptoWire and OptoMonitor, instruments that assess the significance of arterial narrowing (stenosis) resulting from coronary heart disease. In the industrial sector, its technology and products can serve various markets, including aerospace, geotechnical, infrastructures, oil and gas, mining, laboratories and others. For the oil and gas market, it provides fiber optic sensor systems that provide real-time pressure and temperature measurements at the bottom of the wells.

See business summary

 

Twitter

Search (past week) for $OPS.CA

  • No tweets found